Related references
Note: Only part of the references are listed.Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials
Luis Ortega-Paz et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
Hanny Al-Samkari et al.
ANNALS OF INTERNAL MEDICINE (2021)
Complement activation and endothelial perturbation parallel COVID-19 severity and activity
Massimo Cugno et al.
JOURNAL OF AUTOIMMUNITY (2021)
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study *
Augusto Di Castelnuovo et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis
Georg Gelbenegger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019
Samuel A. P. Short et al.
CRITICAL CARE MEDICINE (2021)
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
Michelle Sholzberg et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 The HEP-COVID Randomized Clinical Trial
Alex C. Spyropoulos et al.
JAMA INTERNAL MEDICINE (2021)
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
Parham Sadeghipour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Inhaled budesonide for early treatment of COVID-19
Markus Zeitlinger et al.
LANCET RESPIRATORY MEDICINE (2021)
Associations of D-Dimer on Admission and Clinical Features of COVID-19 Patients: A Systematic Review, Meta-Analysis, and Meta-Regression
Runzhen Zhao et al.
FRONTIERS IN IMMUNOLOGY (2021)
Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: A multi-center, open-label, randomized controlled trial
Usha S. Perepu et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Anticoagulation in COVID-19: reaction to the ACTION trial
Jeffrey S Berger et al.
LANCET (2021)
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Renato D. Lopes et al.
LANCET (2021)
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Patrick R. Lawler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Surviving Covid-19 with Heparin?
Hugo ten Cate
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
Seda Bilaloglu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Thomas Mandel Clausen et al.
CELL (2020)
Severe COVID-19 Is a Microvascular Disease
Charles J. Lowenstein et al.
CIRCULATION (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Routine haematological parameters in COVID-19 prognosis
David Pereyra et al.
Lancet Haematology (2020)
Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
Baranca Buijsers et al.
EBIOMEDICINE (2020)
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
Courtney J. Mycroft-West et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulation and bleeding risk in patients with COVID-19
Nancy Musoke et al.
THROMBOSIS RESEARCH (2020)
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Anna Cristina Bertoldi Lemos et al.
THROMBOSIS RESEARCH (2020)
ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk Factors
Zofia Wicik et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness
Catalin Tufanaru et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
A basic introduction to fixed-effect and random-effects models for meta-analysis
Michael Borenstein et al.
RESEARCH SYNTHESIS METHODS (2010)
Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
Dagmar Kubitza et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)